日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议

Armstrong, Andrew J; Morris, Michael J; Abida, Wassim; Aggarwal, Rahul R; Antonarakis, Emmanuel S; Attard, Gerhardt; Beltran, Himisha; Bryce, Alan; Carducci, Michael A; Cheng, Heather H; Chen, Delphine L; Chi, Kim N; Childs, Daniel S; Dahut, William; Emmett, Louise; Fizazi, Karim; Gafita, Andrei; George, Daniel J; Hermann, Ken; Hofman, Michael S; Hope, Thomas; Hussain, Maha; Kelly, W Kevin; Kessler, Elizabeth; Kuo, Phillip H; Lang, Joshua; Liu, Glenn; Marshall, Catherine H; Morgans, Alicia K; McKay, Rana R; Nanus, David; Nelson, Peter; Paller, Channing; Reichert, Zachery R; Ryan, Charles J; Sartor, A Oliver; Schöder, Heiko; Schwartz, Lawrence H; Sharifi, Nima; Stadler, Walter M; Stein, Mark; Sternberg, Cora N; Szmulewitz, Russell Z; Tagawa, Scott T; Sokolova, Alexandra O; Wyatt, Alex W; Yamoah, Kosj; Yu, Evan Y; Halabi, Susan; Scher, Howard I

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS

ARAMIS研究中,根治性前列腺切除术或放射治疗等既往局部治疗对接受达罗鲁胺治疗患者的疗效和生活质量的影响

Saar, Matthias; Fizazi, Karim; Shore, Neal D; Smith, Matthew; Damber, Jan-Erik; Semenov, Andrey; Ribal, Maria J; Birtle, Alison; Rigaud, Jérôme; Wallis, Christopher J D; Grimm, Marc-Oliver; Halabi, Susan; Armstrong, Andrew J; Mohamed, Ateesha F; Adorjan, Patrick; Srinivasan, Shankar; Verholen, Frank; Morgans, Alicia K; Siemens, D Robert

Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI)

使用雄激素受体通路抑制剂 (ARPI) 治疗 SPOP 突变去势抵抗性前列腺癌 (CRPC) 患者的疗效

Park, Joseph J; Howard, Lauren E; Fragkogianni, Stamatina; George, Daniel J; Armstrong, Andrew J

Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review

恩扎卢胺治疗晚期前列腺癌患者(涵盖疾病谱):简明语言综述

Dato, Paul E; De La Cerda, Jose; Armstrong, Andrew J; Azad, Arun A; Conduit, Ciara; Haas, Gabriel P; Kernen, Kenneth; Klaassen, Zachary W; Patel, Raj; Saad, Fred; Shore, Neal D; Freedland, Stephen J; Karsh, Lawrence I

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01

Saruparib联合雄激素受体通路抑制剂治疗转移性激素敏感性前列腺癌:EvoPAR-Prostate01

Azad, Arun A; Agarwal, Neeraj; Armstrong, Andrew J; Hellmis, Eva; Sugimoto, Mikio; Ürün, Yüksel; Xing, Nianzeng; Aregay, Mehreteab; Lima, Julianne; Meulendijks, Didier; Chi, Kim N

Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory Properties

开发具有免疫刺激特性的靶向STEAP1的前列腺癌特异性抗体药物偶联物平台

Wang, John Shuhan; Sodhi, Sirajbir S; Tsao, Li-Chung; Lin, Guang Han; Moon, Nicole; Zhang, Qiang; Liu, Bushangqing; Penaranda, Juliet; Trotter, Timothy N; Somarelli, Jason A; Armstrong, Andrew J; Lyerly, H Kim; Wang, Guangdi; Hartman, Zachary C

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

循环肿瘤DNA中的致病性基因组改变可预测转移性去势抵抗性前列腺癌患者的总生存期

Halabi, Susan; Guo, Siyuan; Luo, Bin; Yu, Chenxi; Knutson, Todd P; Kobilka, Anna; Lyman, Jacqueline; Beltran, Himisha; Antonarakis, Emmanuel S; Galsky, Matthew D; Rosenberg, Jonathan E; Ryan, Charles J; Small, Eric J; Kelly, W Kevin; Morris, Michael J; Page, David; Dehm, Scott M; Armstrong, Andrew J

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

帕博利珠单抗联合多西他赛对比单药多西他赛治疗既往接受过治疗的转移性去势抵抗性前列腺癌:随机、双盲、III期KEYNOTE-921试验

Petrylak, Daniel P; Ratta, Raffaele; Matsubara, Nobuaki; Korbenfeld, Ernesto; Gafanov, Rustem; Mourey, Loic; Todenhöfer, Tilman; Gurney, Howard; Kramer, Gero; Bergman, Andries M; Zalewski, Pawel; De Santis, Maria; Armstrong, Andrew J; Gerritsen, Winald; Pachynski, Russell; Byun, Seok Soo; Retz, Margitta; Levesque, Eric; McDermott, Ray; Bracarda, Sergio; Manneh, Ray; Levartovsky, Meital; Li, Xin Tong; Schloss, Charles; Poehlein, Christian H; Fizazi, Karim

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

开发和验证一种人工智能数字病理生物标志物,用于预测高危前列腺癌男性患者在多项 III 期试验中从长期激素治疗和放射治疗中获益的情况

Armstrong, Andrew J; Liu, Vinnie Y T; Selvaraju, Ramprasaath R; Chen, Emmalyn; Simko, Jeffry P; DeVries, Sandy; Sartor, Oliver; Sandler, Howard M; Mohamad, Osama; Huang, Huei-Chung; Griffin, Jacqueline; Yamashita, Rikiya; Esteva, Andre; Tran, Phuoc T; Spratt, Daniel E; Carson, John Hi; Peters, Christopher; Gore, Elizabeth; Lee, Steve P; Monson, Jedidiah M; Augspurger, Mark E; El-Gayed, Ali; Rodgers, Joseph P; McKay, Rana; Morgan, Todd; Feng, Felix Y; Nguyen, Paul L

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

cfDNA片段组学指标和商业靶向测序panel的分析

Helzer, Kyle T; Sharifi, Marina N; Sperger, Jamie M; Chrostek, Matthew R; Bootsma, Matthew L; Reese, Shannon R; Taylor, Amy; Kaufmann, Katie R; Krause, Hannah; Schehr, Jennifer; Sethakorn, Nan; Kosoff, David; Kyriakopoulos, Christos E; Bassetti, Michael; Blitzer, Grace; Floberg, John; Sjöström, Martin; Armstrong, Andrew J; Beltran, Himisha; McKay, Rana R; Feng, Felix Y; O'Regan, Ruth; Wisinski, Kari B; Emamekhoo, Hamid; Wyatt, Alex W; Lang, Joshua M; Zhao, Shuang G